Back

Predictors of LV reverse remodeling after SAVR: insights from a prospective TTE and CMR study in patients with severe aortic stenosis.

1 September 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Myocardial ischaemia and heart failure: insight from multimodality imaging Imaging of Valvular Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rita Reis Santos

Hospital Santa Cruz, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
The role of semi-quantitative parameters of thallium-201 myocardial perfusion imaging in predicting mortality rate among CKD population
Doctor Y. Liu (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Rosuvastatin effect on atherosclerotic plaque microcalcification
Doctor M. Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes
Mr M. Alghamdi (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
The correlation between cardiac magnetic resonance imaging and echocardiography in patients with severe ischaemic cardiomyopathy
Doctor T. Aklilu (London, GB)
Abstract Slides Video
Presentation thumbnail
Trend in culprit plaque phenotype in ACS patients over the past 10 years
Doctor K. Suzuki (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial ischaemia and heart failure: insight from multimodality imaging

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome
thumbnail
Congress Presentation
Is relative aortic valve load determinant of left ventricular remodeling in patients with severe aortic stenosis referred for surgical valve replacement?
thumbnail
Congress Session
Exploring valvular and congenital heart disease with cardiac magnetic resonance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources